Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 16,426 | 11,621 | 5,941 | 35,729 | 0 |
| Operating Income | -16,426 | -11,621 | -5,941 | -35,729 | N/A |
| Other Income | -403 | -2,554 | -2,205 | -1,096 | 0 |
| Pre-tax Income | -16,829 | -14,175 | -8,146 | -36,825 | 0 |
| Net Income Continuous | -16,829 | -14,175 | -8,146 | -36,825 | N/A |
| Net Income | $-16,829 | $-14,175 | $-8,146 | $-36,825 | $N/A |
| EPS Basic Total Ops | 32.81 | -8.96 | -5.54 | -27.26 | N/A |
| EPS Basic Continuous Ops | 32.81 | -8.96 | -5.54 | -27.26 | N/A |
| EPS Diluted Total Ops | 32.81 | -8.96 | -5.54 | -27.26 | N/A |
| EPS Diluted Continuous Ops | 32.81 | -8.96 | -5.54 | -27.26 | N/A |
| EBITDA(a) | $-16,268 | $-11,462 | $-5,724 | $-35,616 | $N/A |